GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Todos Medical TOMDF · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 4 Nov 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2022

Revenue

$7.7m

FY2014FY2022

Net income

−$25.0m

FY2014FY2022

Free cash flow

−$2.8m

FY2014FY2022

Shareholders' equity

−$35.5m

FY2014FY2022

Income statement

Fiscal years

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue$7.7m$12.2m$5.2m——————
Research and development$620,000$824,000$9.9m$755,699$459,184$720,527$317,907$374,023$336,474
Operating income−$9.7m−$9.3m−$14.3m−$3.5m−$1.4m−$1.3m−$728,889−$830,980−$400,846
Net income−$25.0m−$43.3m−$29.8m−$9.8m−$457,541−$2.7m−$653,461−$818,541−$322,067
Diluted earnings per share-0.02-0.06-0.08-0.01-0.00-0.00-0.00-0.02-0.01

Balance sheet

At each fiscal year end

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$15.3m$15.1m$6.0m$90,901$199,125$816,429$583,812$292,280$128,686
Cash and short-term investments$34,000$189,000$935,000$12,155$63,550$683,202$439,077$161,751$60,600
Total liabilities$50.2m$39.3m$17.0m$6.3m$1.4m$2.2m$987,761$819,790$716,379
Debt$38.3m$31.8m$11.4m$3.9m$629,937$659,526$592,868$608,435$616,636
Shareholders' equity−$35.5m−$24.2m−$11.0m−$6.2m−$1.2m−$1.3m−$403,949−$527,510−$587,693
Shares outstanding1,426m737m376m1,426m1,426m1,426m1,426m47m30m

Cash flow

Fiscal years

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations−$2.7m−$11.2m−$2.6m−$1.3m−$1.1m−$904,410−$469,389−$614,654−$317,548
Capital spending−$74,000−$1.1m−$2.5m−$1,073−$15,370−$3,596−$34,971−$117,788−$2,021
Free cash flow−$2.8m−$12.3m−$5.0m−$1.3m−$1.1m−$908,006−$504,360−$732,442−$319,569

Latest quarters

By quarter end

Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021
Revenue$1.4m$1.9m$2.2m$2.2m$4.5m$1.0m$1.7m$5.0m
Operating income−$2.0m−$1.7m−$1.8m−$3.4m−$3.6m−$2.5m−$1.7m−$1.8m
Net income−$5.0m−$6.0m−$7.3m−$8.5m−$18.8m−$10.4m$3.4m−$17.6m
Diluted earnings per share-0.00-0.00-0.01-0.01-0.03-0.010.00-0.02
Cash from operations——−$1.0m−$1.0m−$1.0m−$3.0m−$2.0m−$3.0m
Capital spending−$1.0m———————
Total assets$15.3m$14.2m$13.8m$13.7m$15.1m$17.2m$17.3m$6.4m
Cash and short-term investments$34,000$57,000$17,000$74,000$189,000$166,000$308,000$136,000
Debt$5.3m$35.8m$35.3m$3.6m$31.6m$22.1m$20.4m$20.9m
Shareholders' equity−$35.5m−$31.2m−$30.4m−$25.2m−$24.2m−$10.5m−$9.0m−$19.5m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income40.5%48.8%188.4%
Net income36.6%56.3%218.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-95.5%———
Net margin-342.8%———

Valuation history

At each fiscal year end

FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-0.0-0.0-0.0-0.0-1.0-0.0
Price to sales0.00.00.1———

Share price return

Finished calendar years

20242023202220212020201920182017
Return33%-93%-87%7%118%9%410%70%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.